Journals / Clinical and Experimental Health Sciences / 2021 / Cilt: 11 - Sayı: 2

Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease

Pages
296–301
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This study shows that there was no statistically significant difference in terms of foveal thickness and macular choroidal thickness in patients with BD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the foveal thickness and macular choroidal thickness on patients who were diagnosed with Behcet’s Disease (BD).
📊
Key Findings & Data:Methods: A total of 60 patients were included in this prospective cross-sectional study.
💡
Conclusion & Impact:Conclusion: This study shows that there was no statistically significant difference in terms of foveal thickness and macular choroidal thickness in patients with BD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the foveal thickness and macular choroidal thickness on patients who were diagnosed with Behcet’s Disease (BD). Methods: A total of 60 patients were included in this prospective cross-sectional study. Patients were divided into two groups. Group 1 consisted of 30 patients who were diagnosed with BD and Group 2 consisted of 30 healthy controls. Detailed ophthalmological examination was performed on both groups and foveal thickness and macular choroidal thickness were measured with Spectral-Domain Optical Coherence Tomography (SD-OCT). To measure the choroidal thickness enhanced depth imaging OCT (EDI-OCT) technique was used. Results: Mean foveal thickness in BD patients was 216.06 ± 53.14 μm and mean subfoveal choroidal thickness was 363.21 ± 85.22 μm. Mean foveal thickness and subfoveal choroidal thickness in healthy controls was 211.65 ± 16.60 μm and 352.83 ± 87.11 μm respectively. There was no statistical significance between patients with BD and patients of the control group regarding foveal and subfoveal choroidal thickness. However, anatomical deformation of Ellipsoid Zone structure in OCT had the most effect on visual acuity (p=0.001). Conclusion: This study shows that there was no statistically significant difference in terms of foveal thickness and macular choroidal thickness in patients with BD.

🔖

Cite This Article

Bozali, E., Erdogan, H., Dursun, A., Ozec, A. V., Aric, M. K., Toker, M. I. (2022). Evaluation of Foveal Thickness and Macular Choroidal Thickness with Optical Coherence Tomography in Behcet’s Disease. Clinical and Experimental Health Sciences, Cilt: 11 - Sayı: 2, 296–301. https://ajindex.com/articles/474182

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Behcet H. Uber rezidivierende, aphthose, durchein Virus verusachte Gaschwure am Mund, am Auge und an den Genitalien. Dermat Wochsch 1937;105:1152-1157
  2. Mittal A, Velaga SB, Falavarjani KG, Nittala MG, Sadda SR. Choroidal thickness in non-ocular Behçet’s disease – A spectraldomain OCT study. J Curr Ophthalmol 2017;29(3):210-213
  3. Charteris D, Barton K, McCartney A, Lightman S. CD4+ Lymphocyte Involvement in Ocular Behcet’s Disease. Autoimmunity 1992;12(3):201-206
  4. Gürler A, Boyvat A, Türsen U. Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med J 1997;38(6):423-427
  5. Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H. Ocular features of Behçet’s disease: an international collaborative study. Br J Ophthalmol 2007;91(12):1579-1582
  6. Özdal P, Ortac S, Taşkintuna I, Firat E. Posterior segment involvement in ocular Behçet’s disease. Eur J Ophthalmol 2002;12(5):424-431
  7. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas HH, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 2004;138(3):373-380
  8. Kim HB. Ophthalmologic manifestation of Behçet’s disease. Yonsei Med J 1997;38(6):390-394
  9. Atmaca L, Sonmez P. Fluorescein and indocyanine green angiography findings in Behçet’s disease. Br J Ophthalmol 2003;87(12):1466-1468
  10. Gedik Ş, Akova YA, Yilmaz G, Bozbeyoğlu S. Indocyanine Green and Fundus Fluorescein Angiographic Findings in Patients with Active Ocular Behçet’s Disease. Ocul Immunol Inflamm 2005;13(1):51-58
  11. Kansu T, Kadayifcilar S. Visual aspects of Behçet’s disease. Curr Neurol Neurosci Rep 2005;5(5):382-388
  12. Klaeger AJ, Tran VT, Hiroz CA, Morisod L, Herbort CP. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behcet’s uveitis. Int Ophthalmol 2004;25(1):57-63
  13. Tekeli O, Özdemir Ö. Heidelberg retina tomograph in ocular Behçet’s disease. Eye 2004;18(2):143-146
  14. Alm A, Bill A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res 1973;15(1):15-29
  15. Laviers H, Zambarakji H. Enhanced depth imaging-OCT of the choroid: a review of the current literature. Graefe’s Archive for Clinical and Experimental Ophthalmology 2014;252(12):1871- 1883
  16. Chung SE, Kang SW, Lee JH, Kim YT. Choroi